Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver
Status:
Withdrawn
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find out what effects radioactive particles,
SIR-spheres, have when injected into the liver, followed by systemic chemotherapy with a
combination of cetuximab and irinotecan compared to those who have systemic therapy alone, in
patients with colon cancer that has metastasized to the liver. The safety of this treatment
and how well it controls the disease will also be studied.